近几年来肺癌发病率逐年增高,临床就诊的大多数患者已属中晚期。ⅢA期非小细胞肺癌属局部晚期,单纯手术或手术加术后辅助化疗效果欠佳。近来的研究认为术前进行新辅助化疗,可减少肿瘤负荷,提高手术根治性切除率,消灭可能存在的微小转移灶,并有助于评价肿瘤对化疗的敏感性,因此 In recent years, the incidence of lung cancer increased year by year, the majority of clinical treatment of patients with advanced disease. Stage IIA non-small cell lung cancer is locally advanced, simple surgery or surgery and postoperative adjuvant chemotherapy ineffective. Recent studies suggest that neoadjuvant chemotherapy before surgery can reduce the tumor burden, improve the radical resection rate of surgery, the elimination of possible micro-metastases, and help to evaluate the sensitivity of the tumor chemotherapy, therefore